검색
Roivant Sciences Ltd
ROIV관심 목록에 추가
38.880USD
+2.260+6.17%
종가 11-06 16:00（ET）
28.08B시가총액
손실P/E TTM
장외 거래 17:02 (ET)38.930USD+0.080+0.21%
장외 거래 17:02 (ET)소유권
주식 보유 통계
마지막 업데이트: Sun, May 10
마지막 업데이트: Sun, May 10
주주
주주 유형
주주
주주
비율
Dexcel Pharma Technologies, Ltd.
14.37%
Fidelity Management & Research Company LLC
9.18%
Morgan Stanley Investment Management Inc. (US)
7.59%
BlackRock Institutional Trust Company, N.A.
5.19%
Ramaswamy (Vivek)
4.71%
기타
58.95%
주주
주주
비율
Dexcel Pharma Technologies, Ltd.
14.37%
Fidelity Management & Research Company LLC
9.18%
Morgan Stanley Investment Management Inc. (US)
7.59%
BlackRock Institutional Trust Company, N.A.
5.19%
Ramaswamy (Vivek)
4.71%
기타
58.95%
주주 유형
주주
비율
Investment Advisor
31.62%
Investment Advisor/Hedge Fund
18.77%
Corporation
14.37%
Hedge Fund
12.46%
Individual Investor
8.47%
Private Equity
4.86%
Research Firm
2.99%
Bank and Trust
0.83%
Sovereign Wealth Fund
0.73%
기타
4.90%
기관 주식 보유
마지막 업데이트: Wed, Apr 1
마지막 업데이트: Wed, Apr 1
보고 기간
기관 수
보유 주식
비율
변동
2026Q1
781
565.52M
79.01%
-23.02M
2025Q4
728
545.59M
76.23%
-26.01M
2025Q3
690
526.70M
77.13%
-109.19M
2025Q2
673
776.63M
112.42%
-147.35M
2025Q1
676
776.88M
113.63%
-136.03M
2024Q4
645
780.70M
109.07%
-147.12M
2024Q3
601
789.51M
107.30%
-83.47M
2024Q2
564
721.13M
95.89%
-110.95M
2024Q1
518
776.24M
96.43%
-47.46M
2023Q4
449
787.20M
97.95%
-13.44M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Dexcel Pharma Technologies, Ltd.
102.85M
14.37%
--
--
Jul 01, 2025
Fidelity Management & Research Company LLC
65.72M
9.18%
+4.99M
+8.22%
Dec 31, 2025
Morgan Stanley Investment Management Inc. (US)
54.36M
7.59%
+13.70M
+33.71%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
37.13M
5.19%
+1.37M
+3.83%
Dec 31, 2025
Ramaswamy (Vivek)
33.71M
4.71%
-13.36M
-28.38%
Dec 31, 2025
QVT Financial LP
26.39M
3.69%
-1.69M
-6.03%
Dec 31, 2025
UBS Financial Services, Inc.
18.16M
2.54%
+16.01M
+745.83%
Dec 31, 2025
State Street Investment Management (US)
17.36M
2.43%
-1.34M
-7.16%
Dec 31, 2025
더 보기
ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Invesco S&P MidCap 400 Pure Growth ETF
3.56%
Adaptiv Select ETF
2.91%
Virtus LifeSci Biotech Products ETF
2.79%
State Street SPDR S&P Biotech ETF
2.67%
WisdomTree US Value Fund
2.3%
ProShares Ultra Nasdaq Biotechnology
1.73%
Goldman Sachs Future Health Care Equity ETF
1.73%
Direxion Daily S&P Biotech Bull 3X Shares
1.41%
Invesco Nasdaq Biotechnology ETF
1.33%
WisdomTree BioRevolution Fund
1.3%
더 보기
Invesco S&P MidCap 400 Pure Growth ETF
비율3.56%
Adaptiv Select ETF
비율2.91%
Virtus LifeSci Biotech Products ETF
비율2.79%
State Street SPDR S&P Biotech ETF
비율2.67%
WisdomTree US Value Fund
비율2.3%
ProShares Ultra Nasdaq Biotechnology
비율1.73%
Goldman Sachs Future Health Care Equity ETF
비율1.73%
Direxion Daily S&P Biotech Bull 3X Shares
비율1.41%
Invesco Nasdaq Biotechnology ETF
비율1.33%
WisdomTree BioRevolution Fund
비율1.3%